Literature DB >> 17410023

Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator?

Ricardo Ribeiro1, António Araújo, Carlos Lopes, Rui Medeiros.   

Abstract

This is a short review focusing on leptin immunoinflammatory mechanisms that ultimately may contribute to lung cancer development. We explored the complex and intricate interaction of leptin with immune cells to propose a pathway of inflammation-associated lung cancer development.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17410023     DOI： 10.1016/s1556-0864(15)30035-6

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


  12 in total

1.  Effects of leptin and leptin receptor gene polymorphisms on lung cancer.

Authors:  Meftun Unsal; Nurten Kara; Nevin Karakus; Sengul Tural; Mehmet Elbistan
Journal:  Tumour Biol       Date:  2014-07-17

2.  Clinical significance of serum adipokines levels in lung cancer.

Authors:  Theodora Kerenidi; Martha Lada; Agori Tsaroucha; Panagiotis Georgoulias; Parthena Mystridou; Konstantinos I Gourgoulianis
Journal:  Med Oncol       Date:  2013-02-22       Impact factor: 3.064

3.  Loss of phosphatase and tensin homolog (PTEN) induces leptin-mediated leptin gene expression: feed-forward loop operating in the lung.

Authors:  Ravi Ramesh Pathak; Aditya Grover; Prerna Malaney; Waise Quarni; Ashish Pandit; Diane Allen-Gipson; Vrushank Davé
Journal:  J Biol Chem       Date:  2013-08-20       Impact factor: 5.157

Review 4.  The role of leptin in the respiratory system: an overview.

Authors:  Foteini Malli; Andriana I Papaioannou; Konstantinos I Gourgoulianis; Zoe Daniil
Journal:  Respir Res       Date:  2010-10-31

5.  Leptin: a correlated Peptide to papillary thyroid carcinoma?

Authors:  Mehdi Hedayati; Parichehr Yaghmaei; Zahra Pooyamanesh; Marjan Zarif Yeganeh; Laleh Hoghooghi Rad
Journal:  J Thyroid Res       Date:  2011-10-05

6.  Induction of osteoclast-like cell formation by leptin-induced soluble intercellular adhesion molecule secreted from cancer cells.

Authors:  Cheng-Fang Tsai; Jia-Hong Chen; Chen-Teng Wu; Pei-Chun Chang; Shu-Lin Wang; Wei-Lan Yeh
Journal:  Ther Adv Med Oncol       Date:  2019-05-14       Impact factor: 8.168

7.  Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma.

Authors:  Qing Ju; Tingping Huang; Yong Zhang; Lei Wu; Jing Geng; Xiaoyan Mu; Tao Yan; Jian Zhang
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

8.  Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization.

Authors:  Wen Zhou; Geoffrey Liu; Rayjean J Hung; Philip C Haycock; Melinda C Aldrich; Angeline S Andrew; Susanne M Arnold; Heike Bickeböller; Stig E Bojesen; Paul Brennan; Hans Brunnström; Olle Melander; Neil E Caporaso; Maria Teresa Landi; Chu Chen; Gary E Goodman; David C Christiani; Angela Cox; John K Field; Mikael Johansson; Lambertus A Kiemeney; Stephen Lam; Philip Lazarus; Loïc Le Marchand; Gad Rennert; Angela Risch; Matthew B Schabath; Sanjay S Shete; Adonina Tardón; Shanbeh Zienolddiny; Hongbing Shen; Christopher I Amos
Journal:  Int J Cancer       Date:  2020-09-23       Impact factor: 7.396

9.  Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue.

Authors:  Ricardo Ribeiro; Cátia Monteiro; Victoria Catalán; Pingzhao Hu; Virgínia Cunha; Amaia Rodríguez; Javier Gómez-Ambrosi; Avelino Fraga; Paulo Príncipe; Carlos Lobato; Francisco Lobo; António Morais; Vitor Silva; José Sanches-Magalhães; Jorge Oliveira; Francisco Pina; Carlos Lopes; Rui Medeiros; Gema Frühbeck
Journal:  BMC Med       Date:  2012-09-25       Impact factor: 8.775

10.  Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy.

Authors:  Wenjun Mou; Hui Xue; Hongli Tong; Shengjie Sun; Zhuhong Zhang; Chunyan Zhang; Qiyu Sun; Jing Dong; Xinyu Wen; Guangtao Yan; Yaping Tian
Journal:  Oncol Lett       Date:  2014-03-21       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.